Worldwide proliferation of carbapenem-resistant gram-negative bacteria

被引：63
|
作者：
Kurokawa, H
Yagi, T
Shibata, N
Shibayama, K
Arakawa, Y
机构：
[1] Natl Inst Infect Dis, Dept Bacterial & Blood Prod, Tokyo 2080011, Japan
[2] Nagoya Univ, Sch Med, Nagoya, Aichi 466, Japan
来源：
LANCET | 1999年 / 354卷 / 9182期
关键词：
D O I：
10.1016/S0140-6736(05)75707-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：955 / 955
页数：1
相关论文
共 50 条
  • [41] Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens
    Lee, Chang-Seop
    Doi, Yohei
    INFECTION AND CHEMOTHERAPY, 2014, 46 (03): : 149 - 164
  • [42] Quercetin inhibits carbapenemase and efflux pump activities among carbapenem-resistant Gram-negative bacteria
    Pal, Arijit
    Tripathi, Anusri
    APMIS, 2020, 128 (03) : 251 - 259
  • [43] Polymyxin B adjuvants against polymyxin B- and carbapenem-resistant Gram-negative bacteria
    Salvaterra Pasquini, Joao Paulo
    Queiroz, Paula Assis
    Rodrigues do Amaral, Pedro Henrique
    da Silva, Thalita Camilo
    Souza Bonfim Mendonca, Patricia de
    Vandresen, Fabio
    Carvalho Ceolis, Joao Pedro
    de Lima Scodro, Regiane Bertin
    Caleffi-Ferracioli, Katiany Rizzieri
    Cardoso, Rosilene Fressatti
    Dias Siqueira, Vera Lucia
    FUTURE MICROBIOLOGY, 2024, 19 (17) : 1445 - 1454
  • [44] Epidemiology, Phenotypic and Genotypic Characterization of Carbapenem-Resistant Gram-Negative Bacteria from a Libyan Hospital
    Slimene, Khouloud
    El Salabi, Allaaeddin
    Dziri, Olfa
    Mathlouthi, Najla
    Diene, Seydina M.
    Mohamed, Elhussan Ahmed
    Amhalhal, Jadalla M. A.
    Aboalgasem, Mohammed O.
    Alrjael, Jomaa F.
    Rolain, Jean-Marc
    Chouchani, Chedly
    MICROBIAL DRUG RESISTANCE, 2023, 29 (08) : 333 - 343
  • [45] Clinical analysis of colistin sulfate in the treatment of pneumonia caused by carbapenem-resistant Gram-negative bacteria
    Xu, Hai-Chang
    Cui, Yan
    Wang, Xue-Ying
    Wu, Hai-Bo
    Li, Wei
    Wang, Dan
    Lin, Na
    Lin, Lin
    Zhang, Ying-Hui
    WORLD JOURNAL OF CLINICAL CASES, 2024, 12 (13)
  • [46] The Place of Meropenem–Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
    Teena Chopra
    Infectious Diseases and Therapy, 2021, 10 : 633 - 635
  • [47] Early identification and optimal management of carbapenem-resistant Gram-negative infection
    Bedos, J. P.
    Daikos, G.
    Dodgson, A. R.
    Pan, A.
    Petrosillo, N.
    Seifert, H.
    Vila, J.
    Ferrer, R.
    Wilson, P.
    JOURNAL OF HOSPITAL INFECTION, 2021, 108 : 158 - 167
  • [48] Unresolved issues in the identification and treatment of carbapenem-resistant Gram-negative organisms
    Kois, Abigail K.
    Nicolau, David P.
    Kuti, Joseph L.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2020, 33 (06) : 482 - 494
  • [49] Infections Caused by Carbapenem-resistant Gram-negative Pathogens in Hospitalized Children
    Maltezou, Helena C.
    Kontopidou, Flora
    Katerelos, Panos
    Daikos, George
    Roilides, Emmanuel
    Theodoridou, Maria
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (04) : E151 - E154
  • [50] Emergence of Carbapenem-Resistant Gram-Negative Isolates in Hospital Settings in Djibouti
    Ragueh, Ayan Ali
    Aboubaker, Mohamed Houmed
    Mohamed, Sitani Idriss
    Rolain, Jean-Marc
    Diene, Seydina M.
    ANTIBIOTICS-BASEL, 2023, 12 (07):
12345